• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Verona Pharma Plc ADR (NQ: VRNA )

    31.75 -0.02 (-0.06%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 840,615
    Open 32.12
    Bid (Size) 31.75 (1)
    Ask (Size) 32.40 (1)
    Prev. Close 31.77
    Today's Range 31.09 - 32.12
    52wk Range 11.39 - 32.88
    Shares Outstanding 480,291,822
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
    The FDA signed off on Regeneron and Sanofi's Dupixent for patients with uncontrolled COPD. 
    Via Investor's Business Daily
    Exposures Product Safety
    Petco, AppLovin, Dave & Buster's And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga

    Performance

    YTD
    +68.79%
    +68.79%
    1 Month
    +15.50%
    +15.50%
    3 Month
    +77.08%
    +77.08%
    6 Month
    +95.14%
    +95.14%
    1 Year
    +115.25%
    +115.25%

    More News

    Read More
    GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With Amgen/AstraZeneca's Drug
    Via Benzinga
    Top 3 Health Care Stocks That May Crash In August
    Via Benzinga
    9 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    Earnings Preview For Verona Pharma
    Via Benzinga
    Expert Ratings for Verona Pharma
    Via Benzinga
    Earnings Scheduled For August 3, 2023
    Via Benzinga
    VRNA Stock Earnings: Verona Pharma Misses EPS for Q2 2024
    Via InvestorPlace
    Top 3 Health Care Stocks You May Want To Dump This Quarter
    Via Benzinga
    First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
    Via Benzinga
    Exposures Product Safety
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
    Via Benzinga
    Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
    Via Investor's Business Daily
    VRNA Stock Earnings: Verona Pharma Misses EPS for Q1 2024
    Via InvestorPlace
    3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
    Via The Motley Fool
    3 Stocks That Could Be Monster Winners in 2024
    Via The Motley Fool
    Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves
    Via Benzinga
    Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal
    Via Talk Markets
    Earnings Scheduled For November 2, 2023
    Via Benzinga
    Earnings Scheduled For May 9, 2023
    Via Benzinga
    Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.